Your browser doesn't support javascript.
loading
Development and validation of reverse phase HPLC method for determination of angiotensin receptor blocking agent irbesartan in plasma.
Nisa, Zebun; Ali, Syed Imran; Rizvi, Mehwish; Khan, Maqsood Ahmed; Sultan, Rafi Akhter; Fatima, Rasheeda; Shaheen, Najma; Zafar, Farya; Kashif, Sadia Suri; Khatian, Najeeb.
Afiliação
  • Nisa Z; Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan.
  • Ali SI; Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan.
  • Rizvi M; Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan.
  • Khan MA; Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan.
  • Sultan RA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Pakistan.
  • Fatima R; Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan.
  • Shaheen N; Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Pakistan.
  • Zafar F; Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Pakistan.
  • Kashif SS; Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan.
  • Khatian N; Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan.
Pak J Pharm Sci ; 32(2 (Supplementary)): 853-858, 2019 Mar.
Article em En | MEDLINE | ID: mdl-31103982
Buscar no Google
Base de dados: MEDLINE Assunto principal: Cromatografia Líquida de Alta Pressão / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Irbesartana Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Cromatografia Líquida de Alta Pressão / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Irbesartana Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article